BioCentury | Aug 1, 2016
Emerging Company Profile
Faster than McDonald
...fluid, among other factors. Though treating MS early is thought to lead to better outcomes, IQuity...
...IQuity plans to launch IsolateMS as a CLIA test in September. To develop the assay, IQuity's...
..."Defective structural RNA processing in relapsing-remitting multiple sclerosis." Genome Biology (2015) Sidebars IQuity Inc. Corporate Profile IQuity Inc....
...IQuity plans to launch IsolateMS as a CLIA test in September. To develop the assay, IQuity's...
..."Defective structural RNA processing in relapsing-remitting multiple sclerosis." Genome Biology (2015) Sidebars IQuity Inc. Corporate Profile IQuity Inc....
